As of May 23
| 0.00 / 0.00%|
Omni Bio Pharmaceutical, Inc. operates as a biopharmaceutical company, which engaes in the exploration of new methods of use of alpha-1 antitrypsin (AAT). It offers AAT, a naurally occurring protein that is essential for normal liver and lung function and has been purified from human blood to treat patients suffering from emphysema due to AAT-deficiency. The company was founded on December 1, 2005 and is headquartered in Fort Collins, CO.
|John F. Riccardi||Chief Financial Officer & Director|